The Latest Cardiac and Vascular News
– New data from the HuMAIN study, which met the primary endpoint of weight loss and several efficacy and pharmacodynamic secondary endpoints, will be presented in a Late Breaking Clinical Research Session – – HU6, a novel oral, once-daily Controlled Metabolic Accelerator, is a new class…
BEIJING, Sept. 23, 2024 /PRNewswire/ — Professor Luo Min, from Beijing Yuhe Integrated Traditional Chinese and Western Medicine Rehabilitation Hospital, has been invited to attend the 36th World Congress on Cardiology and Heart Disease on October 17-18, 2024 in London to introduce his…
NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing capabilities and developed in-house product…
McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their key responsibilities include offering strategic guidance, leveraging […]
September 20, 2024 10:27 AM Eastern Daylight Time GLASGOW, Scotland–(BUSINESS WIRE)–Maja Schmidt, in collaboration with Neuranics Limited and the University of Edinburgh, has been awarded the highly coveted Royal Commission for the Exhibition of 1851 Industrial Fellowship for her innovative AI-driven remote heart health monitoring project. This initiative aims to […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the launch of the Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety […]
PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ — Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and…
MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the first two patients have been treated in SPIRARE I (NCT06571760), a multicenter study of the Vertex Pulmonary Embolectomy System using the company’s Endoportal Control™ platform technology. […]
TAMPA, Fla. and WAYNE, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — NewVue, a leader in cloud-native radiology workflow solutions, and Konica Minolta Healthcare Americas, Inc., a leading provider of medical diagnostic imaging and healthcare information technology, announce a strategic partner agreement. This partnership allows Konica Minolta to offer NewVue’s innovative EmpowerSuite Radiology Workflow Orchestrator and Command Center to its extensive network of healthcare customers across the US, integrating seamlessly with Konica Minolta’s Exa® Platform to enhance radiology workflows. EmpowerSuite is a key component of Konica Minolta’s enterprise imaging portfolio.
BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new commercial supply contract with a top-tier mid-sized dialysis operator for the supply of DefenCath® (taurolidine and heparin) to dialysis clinics in the US. This new agreement will provide access to DefenCath for adult patients with kidney failure receiving hemodialysis through a central venous catheter at more than 250 outpatient dialysis clinics located across the United States.
